Literature DB >> 21633049

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.

E Van Cutsem1, M Dicato, R Geva, N Arber, Y Bang, A Benson, A Cervantes, E Diaz-Rubio, M Ducreux, R Glynne-Jones, A Grothey, D Haller, K Haustermans, D Kerr, B Nordlinger, J Marshall, B D Minsky, Y K Kang, R Labianca, F Lordick, A Ohtsu, N Pavlidis, A Roth, P Rougier, H J Schmoll, A Sobrero, J Tabernero, C Van de Velde, J Zalcberg.   

Abstract

Well-recognized experts in the field of gastric cancer discussed during the 12th European Society Medical Oncology (ESMO)/World Congress Gastrointestinal Cancer (WCGIC) in Barcelona many important and controversial topics on the diagnosis and management of patients with gastric cancer. This article summarizes the recommendations and expert opinion on gastric cancer. It discusses and reflects on the regional differences in the incidence and care of gastric cancer, the definition of gastro-esophageal junction and its implication for treatment strategies and presents the latest recommendations in the staging and treatment of primary and metastatic gastric cancer. Recognition is given to the need for larger and well-designed clinical trials to answer many open questions.

Entities:  

Mesh:

Year:  2011        PMID: 21633049     DOI: 10.1093/annonc/mdr284

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  47 in total

1.  To resect or not resect in metastatic gastric cancer: that is the question!

Authors:  Florian Lordick
Journal:  Gastric Cancer       Date:  2012-07       Impact factor: 7.370

2.  Novel circular RNA circNF1 acts as a molecular sponge, promoting gastric cancer by absorbing miR-16.

Authors:  Zhe Wang; Ke Ma; Steffie Pitts; Yulan Cheng; Xi Liu; Xiquan Ke; Samuel Kovaka; Hassan Ashktorab; Duane T Smoot; Michael Schatz; Zhirong Wang; Stephen J Meltzer
Journal:  Endocr Relat Cancer       Date:  2019-03       Impact factor: 5.678

Review 3.  Association of IL-17 polymorphisms with gastric cancer risk in Asian populations.

Authors:  Zi-Wen Long; Hong-Mei Yu; Ya-Nong Wang; Dan Liu; Yan-Zhi Chen; Yu-Xia Zhao; Lu Bai
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

4.  Usefulness of the log odds of positive lymph nodes to predict and discriminate prognosis in gastric carcinomas.

Authors:  A Calero; J Escrig-Sos; F Mingol; A Arroyo; D Martinez-Ramos; M de Juan; J L Salvador-Sanchis; E Garcia-Granero; R Calpena; F J Lacueva
Journal:  J Gastrointest Surg       Date:  2015-01-06       Impact factor: 3.452

5.  Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC).

Authors:  S Keskin; I Yıldız; F Sen; F Aydogan; L Kilic; M Ekenel; S Saglam; B Sakar; R Disci; F Aykan
Journal:  Clin Transl Oncol       Date:  2012-10-02       Impact factor: 3.405

6.  BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt/β-catenin signaling.

Authors:  Wei Yang; Bian Wu; Ning Ma; Yongfang Wang; Jianhui Guo; Jun Zhu; Sihui Zhao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-05-28       Impact factor: 2.416

7.  A long non-coding RNA signature to improve prognosis prediction of gastric cancer.

Authors:  Xiaoqiang Zhu; Xianglong Tian; Chenyang Yu; Chaoqin Shen; Tingting Yan; Jie Hong; Zheng Wang; Jing-Yuan Fang; Haoyan Chen
Journal:  Mol Cancer       Date:  2016-09-20       Impact factor: 27.401

8.  Chemotherapy treatment patterns and neutropenia management in gastric cancer.

Authors:  Ewa Kalinka-Warzocha; Javier Gallego Plazas; Laurent Mineur; Tomas Salek; Alain Hendlisz; Lucy DeCosta; Florian D Vogl; Rodolfo Passalacqua
Journal:  Gastric Cancer       Date:  2014-05-05       Impact factor: 7.370

Review 9.  Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review.

Authors:  Rebekka Schirren; Daniel Reim; Alexander R Novotny
Journal:  Ther Adv Med Oncol       Date:  2015-01       Impact factor: 8.168

10.  What studies are appropriate and necessary for staging gastric adenocarcinoma? Results of an international RAND/UCLA expert panel.

Authors:  Matthew Dixon; Roberta Cardoso; Jill Tinmouth; Lucy Helyer; Calvin Law; Carol Swallow; Lawrence Paszat; Robin McLeod; Rajini Seevaratnam; Alyson Mahar; Natalie G Coburn
Journal:  Gastric Cancer       Date:  2013-04-30       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.